Veterinary pharmacy pushes toward formal specialty recognition

Veterinary pharmacy is moving closer to formal specialty recognition, though it isn't there yet. The push highlighted in Clinician’s Brief comes amid a broader effort by the American College of Veterinary Pharmacists, the International College of Veterinary Pharmacy, and the Society of Veterinary Hospital Pharmacists to secure recognition from the Board of Pharmacy Specialties, which began evaluating the field through a veterinary pharmacy job analysis launched in July 2024. That process was designed to determine whether veterinary pharmacy has the scope, competencies, and practitioner base needed for a formal certification program, and by late 2025 the coalition had moved into petition-building and profession-wide support gathering. Meanwhile, the International College of Veterinary Pharmacy says it already offers the only board certification currently available to pharmacists in veterinary pharmacy, along with residency accreditation efforts. Clinician’s Brief framed the issue in practical terms, asking whether a formal specialty would help close persistent training gaps as veterinary teams manage increasingly complex therapeutics, from compounding and species-specific dosing to newer drug classes like monoclonal antibodies and antimicrobial stewardship decisions. (prnewswire.com)

Why it matters: For veterinary professionals, the debate is less about titles than about medication safety, workflow, and team-based care. A recognized veterinary pharmacy specialty could help standardize advanced training in species-specific dosing, compounding, excipient risks, antimicrobial stewardship, and formulary management, all areas where veterinary practices often rely on uneven pharmacist familiarity with animal patients. That matters even more as practices adopt newer therapies such as monoclonal antibodies, where rapid product growth can outpace frontline familiarity, and as clinicians look for better stewardship tools around antibiotic prescribing, including delayed or “wait-and-see” approaches that have reduced unnecessary antibiotic use in human medicine. It could also give referral hospitals, academic centers, and large practice groups a clearer framework for hiring and collaborating with pharmacists who have validated veterinary expertise. (vetmeds.org)

What to watch: Watch for whether the Board of Pharmacy Specialties advances from petition review to formal recognition steps, which would signal a new credentialing pathway with implications for hospital pharmacy teams, training programs, and interprofessional care. It will also be worth watching whether the conversation broadens beyond credentialing to workforce access and economics, since Clinician’s Brief has recently tied veterinary care capacity to bigger system pressures including uneven geographic access to veterinarians and the financial realities shaping the future veterinary workforce. (prnewswire.com)